Green Cross Cell Signs Contract for Clinical Trial Drug Contract Manufacturing Organization (CMO) Services
[Asia Economy Reporter Oh Ju-yeon] Green Cross Cell announced on the 22nd that it has signed a contract for contract manufacturing organization (CMO) of clinical trial drugs worth 2.252 billion KRW with Green Cross LabCell.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Man in His 30s Dies After Assaulting Father and Falling from Yongin Apartment
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
It also separately announced that it has signed a CMO contract worth 5.2 billion KRW with Artiva Biotherapeutics, Inc. in the United States.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
